healthcare

Image for German financial regulator expands Gerresheimer accounting investigation, launches new auditFinance

German Financial Regulator Expands Gerresheimer Accounting Investigation, Launches New Audit

Image for Novartis to build radioligand therapy site in Texas to expand US manufacturingFinance

Novartis to Build Radioligand Therapy Site in Texas to Expand US Manufacturing

Image for UK drug regulator seizes 2,000 doses of illegal weight-loss drugs in latest crackdownFinance

UK Drug Regulator Seizes 2,000 Doses of Illegal Weight-Loss Drugs in Latest Crackdown

Image for GSK to buy 35Pharma for $950 million in CEO Miel's second major dealFinance

Gsk to Buy 35Pharma for $950 Million in CEO Miel's Second Major Deal

Image for Eye-care group Alcon expects product launches to drive 2026 sales, profitability

Eye-Care Group Alcon Expects Product Launches to Drive 2026 Sales, Profitability

Date: February 25, 2026

Feb 25 (Reuters) - Alcon on Tuesday forecast 2026 sales growth largely in line with market estimates and guided for a significant expansion in its operating margin, signalling confidence that product...

Image for Sensodyne maker Haleon forecasts below-target 2026 growth on weak demand in US

Sensodyne Maker Haleon Forecasts Below-Target 2026 Growth on Weak Demand in US

Date: February 25, 2026

Feb 25 (Reuters) - British consumer healthcare group Haleon reported a slowdown in fourth‑quarter revenue growth on Wednesday, as a delayed flu season hit sales of its respiratory-health products. A...

Image for Healthcare group Fresenius' 2026 outlook falls short of expectations

Healthcare Group Fresenius' 2026 Outlook Falls Short of Expectations

Date: February 25, 2026

Feb 25 (Reuters) - German healthcare group Fresenius narrowly beat analysts' expectations for fourth-quarter adjusted revenue on Wednesday, helped by a better performance at its hospital operator unit...

Image for Novo Nordisk to cut US list prices of Ozempic, Wegovy as of 2027

Novo Nordisk to Cut US List Prices of Ozempic, Wegovy as of 2027

Date: February 24, 2026

COPENHAGEN, Feb 24 (Reuters) - Danish drugmaker Novo Nordisk said on Tuesday it plans to slash the U.S. list prices of its blockbuster weight-loss drug Wegovy and diabetes drug Ozempic by up to 50%...

Image for Novo Nordisk to halve US list price of Wegovy from 2027

Novo Nordisk to Halve US List Price of Wegovy From 2027

Date: February 24, 2026

Feb 24 (Reuters) - Danish drugmaker Novo Nordisk plans to slash U.S. list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 50% starting next year, the Wall Street...

Image for UK medical products maker Convatec lifts medium‑term revenue growth target

UK Medical Products Maker Convatec Lifts Medium‑term Revenue Growth Target

Date: February 24, 2026

Feb 24 (Reuters) - Convatec lifted its medium-term organic revenue growth target on Tuesday, citing a strengthening medical product pipeline, after the British company posted a more than 12% rise in...